AAAAAA
Results:
1-19
|
Results: 19
Authors:
WILSON K
BRADBURY A
WHYMAN M
HOSKINS P
LEE A
FOWKES G
MCCOLLUM P
RUCKLEY CV
Citation: K. Wilson et al., RELATIONSHIP BETWEEN ABDOMINAL AORTIC-ANEURYSM WALL COMPLIANCE AND CLINICAL OUTCOME - A PRELIMINARY-ANALYSIS, European journal of vascular and endovascular surgery, 15(6), 1998, pp. 472-477
Authors:
HOSKINS P
EISENHAUER E
BEARE S
ROY M
DROUIN P
STUART G
BRYSON P
GRIMSHAW R
CAPSTICK V
ZEE B
Citation: P. Hoskins et al., RANDOMIZED PHASE-II STUDY OF 2 SCHEDULES OF TOPOTECAN IN PREVIOUSLY TREATED PATIENTS WITH OVARIAN-CANCER - A NATIONAL-CANCER-INSTITUTE OF CANADA CLINICAL-TRIALS GROUP-STUDY, Journal of clinical oncology, 16(6), 1998, pp. 2233-2237
Authors:
LATREILLE J
PATER J
JOHNSTON D
LABERGE F
STEWART D
RUSTHOVEN J
HOSKINS P
FINDLAY B
MCMURTRIE E
YELLE L
WILLIAMS C
WALDE D
ERNST S
DHALIWAL H
WARR D
SHEPHERD F
MEE D
NISHIMURA L
OSOBA D
ZEE B
Citation: J. Latreille et al., USE OF DEXAMETHASONE AND GRANISETRON IN THE CONTROL OF DELAYED EMESISFOR PATIENTS WHO RECEIVE HIGHLY EMETOGENIC CHEMOTHERAPY, Journal of clinical oncology, 16(3), 1998, pp. 1174-1178
Authors:
HOSKINS P
TU D
JAMES K
PATER J
KOSKI B
Citation: P. Hoskins et al., FACTORS PREDICTIVE OF SURVIVAL AFTER FIRST RELAPSE OR PROGRESSION IN ADVANCED EPITHELIAL OVARIAN-CARCINOMA - A PREDICTION TREE ANALYSIS-DERIVED MODEL WITH TEST AND VALIDATION GROUPS, Gynecologic oncology (Print), 70(2), 1998, pp. 224-230
Authors:
WILSON K
BRADBURY AW
WHYMAN M
HOSKINS P
MCCOLLUM P
LEE A
FOWKES FGR
RUCKLEY CV
Citation: K. Wilson et al., ABDOMINAL AORTIC-ANEURYSM WALL COMPLIANCE AND FUTURE RISK OF RUPTURE - A PRELIMINARY-ANALYSIS, British Journal of Surgery, 85(4), 1998, pp. 555-555
Authors:
BRITTEN C
HOSKINS P
SWENERTON K
PIKE J
WONG F
Citation: C. Britten et al., COMBINED LOCAL AND SYSTEMIC THERAPY FOR SMALL-CELL CARCINOMA OF THE ENDOMETRIUM, International journal of gynecological cancer, 7(6), 1997, pp. 480-485
Authors:
PATER JL
LOFTERS WS
ZEE B
DEMPSEY E
WALDE D
MOQUIN JP
WILSON K
HOSKINS P
GUEVIN RM
VERMA S
NAVARI R
KROOK JE
HAINSWORTH J
PALMER M
CHIN C
Citation: Jl. Pater et al., THE ROLE OF THE 5-HT3 ANTAGONISTS ONDANSETRON AND DOLASETRON IN THE CONTROL OF DELAYED-ONSET NAUSEA AND VOMITING IN PATIENTS RECEIVING MODERATELY EMETOGENIC CHEMOTHERAPY, Annals of oncology, 8(2), 1997, pp. 181-185
Authors:
OREILLY SE
CONNORS JM
MACPHERSON N
KLASA R
HOSKINS P
Citation: Se. Oreilly et al., MALIGNANT-LYMPHOMAS IN THE ELDERLY, Clinics in geriatric medicine, 13(2), 1997, pp. 251
Authors:
LOFTERS WS
PATER JL
ZEE B
DEMPSEY E
WALDE D
MOQUIN JP
WILSON K
HOSKINS P
GUEVIN RM
VERMAN S
NAVARI R
KROOK JE
HAINSWORTH J
PALMER M
CHIN C
Citation: Ws. Lofters et al., PHASE-III DOUBLE-BLIND COMPARISON OF DOLASETRON MESYLATE AND ONDANSETRON AND AN EVALUATION OF THE ADDITIVE ROLE OF DEXAMETHASONE IN THE PREVENTION OF ACUTE AND DELAYED NAUSEA AND VOMITING DUE TO MODERATELY EMETOGENIC CHEMOTHERAPY, Journal of clinical oncology, 15(8), 1997, pp. 2966-2973
Authors:
KLASA R
CONNORS J
GASCOYNE R
HOSKINS P
OREILLY S
SHENKIER T
Citation: R. Klasa et al., CPF (CYCLOPHOSPHAMIDE, PREDNISONE, FLUDARABINE) IN ADVANCED-STAGE PREVIOUSLY UNTREATED LOW-GRADE AND MANTLE CELL LYMPHOMA, Blood, 90(10), 1997, pp. 1527-1527
Authors:
GASCOYNE RD
ADOMAT SA
KRAJEWSKI S
KRAJEWSKA M
HORSMAN DE
TOLCHER AW
OREILLY SE
HOSKINS P
COLDMAN AJ
REED JC
CONNORS JM
Citation: Rd. Gascoyne et al., PROGNOSTIC-SIGNIFICANCE OF BCL-2 PROTEIN EXPRESSION AND BCL-2 GENE REARRANGEMENT IN DIFFUSE AGGRESSIVE NON-HODGKINS-LYMPHOMA, Blood, 90(1), 1997, pp. 244-251
Authors:
SWENERTON K
HOSKINS P
STUART G
BATIST G
PIKE J
ONETTO N
FISHER B
EISENHAUER E
Citation: K. Swenerton et al., A PHASE-I STUDY OF BIWEEKLY PACLITAXEL CISPLATIN AS INITIAL THERAPY FOR ADVANCED OVARIAN-CANCER - A STUDY OF THE NATIONAL-CANCER-INSTITUTE OF CANADA CLINICAL-TRIALS GROUP/, Annals of oncology, 7(10), 1996, pp. 1077-1079
Authors:
JOHNSTON D
LATREILLE J
LABERGE F
STEWART D
RUSTHOVEN J
FINDLAY B
ERNST S
WILLIAMS CKO
HOSKINS P
YELLE L
MCMURTRIE E
DHALIWAL H
NISHIMURA L
PATER J
ZEE B
Citation: D. Johnston et al., PREVENTING NAUSEA AND VOMITING DURING DAYS 2-7 FOLLOWING HIGH-DOSE CISPLATIN CHEMOTHERAPY (HDCP), European journal of cancer, 31A, 1995, pp. 1204-1204
Authors:
LATREILLE J
STEWART D
LABERGE F
HOSKINS P
RUSTHOVEN J
MCMURTRIE E
WARR D
YELLE L
WALDE D
SHEPHERD F
DHALIWAL H
FINDLAY B
MEE D
PATER J
ZEE B
JOHNSTON D
Citation: J. Latreille et al., DEXAMETHASONE IMPROVES THE EFFICACY OF GRANISETRON IN THE FIRST 24 H FOLLOWING HIGH-DOSE CISPLATIN CHEMOTHERAPY, Supportive care in cancer, 3(5), 1995, pp. 307-312
Authors:
KAIZER L
WARR D
HOSKINS P
LATREILLE J
LOFTERS W
YAU J
PALMER M
ZEE B
LEVY M
PATER J
Citation: L. Kaizer et al., EFFECT OF SCHEDULE AND MAINTENANCE ON THE ANTIEMETIC EFFICACY OF ONDANSETRON COMBINED WITH DEXAMETHASONE IN ACUTE AND DELAYED NAUSEA AND EMESIS IN PATIENTS RECEIVING MODERATELY EMETOGENIC CHEMOTHERAPY - A PHASE-III TRIAL BY THE NATIONAL-CANCER-INSTITUTE OF CANADA CLINICAL-TRIALSGROUP, Journal of clinical oncology, 12(5), 1994, pp. 1050-1057
Authors:
STONEBRIDGE P
HOSKINS P
ALLAN P
Citation: P. Stonebridge et al., IN-VIVO STABLE SPIRAL LAMINAR-FLOW, British Journal of Surgery, 81(4), 1994, pp. 613-613
Authors:
OREILLY SE
CONNORS JM
HOWDLE S
HOSKINS P
KLASA R
KLIMO P
STUART DS
Citation: Se. Oreilly et al., IN SEARCH OF AN OPTIMAL REGIMEN FOR ELDERLY PATIENTS WITH ADVANCED-STAGE DIFFUSE LARGE-CELL LYMPHOMA - RESULTS OF A PHASE-II STUDY OF P-DOCE CHEMOTHERAPY, Journal of clinical oncology, 11(11), 1993, pp. 2250-2257
Authors:
JOHNSTONE FD
PRESCOTT R
HOSKINS P
GREER IA
MCGLEW T
COMPTON M
Citation: Fd. Johnstone et al., THE EFFECT OF INTRODUCTION OF UMBILICAL DOPPLER RECORDINGS TO OBSTETRIC PRACTICE, British journal of obstetrics and gynaecology, 100(8), 1993, pp. 733-741
Authors:
JORDAN S
MERRETT S
OHARE K
TAIT M
QUINN A
HOSKINS P
GUTTLER M
WORDSWORTH B
ROWE M
Citation: S. Jordan et al., MUSIC AND DANCE -BALLETS CONDUCT-FOR-DANCE-PROJECT( AN INTERVIEW WITHTHE PARTICIPANTS OF THE ROYAL), DANCING TIMES, 83(996), 1993, pp. 1165
Risultati:
1-19
|